Skip to content
Screener

Telomir Pharmaceuticals, Inc. TELO Q2 2025 earnings

Reported August 14, 2025 · Before market open

EPS-$0.17Miss by $0.09
EPS estimate-$0.08

Next report

Dec 2, 2026 (in a month)
Revenue estimate$500.0K
EPS estimate-$0.03

FAQ

When did Telomir Pharmaceuticals, Inc. report Q2 2025 earnings?
Telomir Pharmaceuticals, Inc. (TELO) reported Q2 2025 earnings on August 14, 2025 before market open.
What were Telomir Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
Telomir Pharmaceuticals, Inc. reported eps of $-0.17 for Q2 2025.
Did Telomir Pharmaceuticals, Inc. beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.08 by $0.09.
How did Telomir Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 240.0% from $-0.05.
Where can I find Telomir Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001641172-25-023970) directly on SEC EDGAR. The filing index links above go to sec.gov.